Earlier HBV prophylaxis in pregnancy effective against mother-to-child transmission

Back to the "HIV and Co-Infections News" list

Earlier initiation of tenofovir disoproxil fumarate (TDF) among pregnant women with highly viremic hepatitis B virus (HBV) infection along with subsequent HBV vaccination in infants is supported for the prevention of mother-to-child transmission in areas where HBV immune globulin (HBIG) is not available, according to study results published in the JAMA.

Read the full story at Infectious Disease Advisor.

 

Get involved

Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?

Subscribe

Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.